Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Conditions
- Lung Cancer Diagnosis
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 20000
- Registration Number
- NCT06122077
- Locations
- ๐บ๐ธ
Horizon Clinical Research Group, Houston, Texas, United States
๐บ๐ธScience 37, Los Angeles, California, United States
๐บ๐ธStamford Hospital, Stamford, Connecticut, United States
The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
- Conditions
- Newly-diagnosed CancersNon-cancer Controls
- Interventions
- Diagnostic Test: Freenome Test
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 788
- Registration Number
- NCT05516927
- Locations
- ๐บ๐ธ
INOVA, Fairfax, Virginia, United States
๐บ๐ธCrisp Regional Hospital, Cordele, Georgia, United States
๐บ๐ธAdvocate Lutheran General Hospital, Park Ridge, Illinois, United States
The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
- Conditions
- Cancer
- Interventions
- Diagnostic Test: Freenome Test
- First Posted Date
- 2022-02-24
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 5400
- Registration Number
- NCT05254834
- Locations
- ๐บ๐ธ
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
๐บ๐ธOncology Consultants, Houston, Texas, United States
๐บ๐ธObjective Health Network (Digestive Research Alliance of Michiana, LLC), South Bend, Indiana, United States
Prevention of Colorectal Cancer Through Multiomics Blood Testing
- Conditions
- Rectal CancerColon LesionAdenomaColon DiseasesColorectal CancerRectal DiseasesGastrointestinal Tract CancersColon NeoplasmPolypColon Cancer
- First Posted Date
- 2020-04-30
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 48995
- Registration Number
- NCT04369053
- Locations
- ๐บ๐ธ
Kaiser Permanente Northern California, Walnut Creek, California, United States
๐บ๐ธClinical Research of California LLC, Walnut Creek, California, United States
๐บ๐ธDenver Digestive Health Specialists, Denver, Colorado, United States
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
- Conditions
- Colo-rectal CancerCancer ColonPolypsCancer, RectumNeoplasms,ColorectalPolyp of ColonAdenomaAdenoma Colon
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 3275
- Registration Number
- NCT03688906
- Locations
- ๐บ๐ธ
Preferred Research Partners, Little Rock, Arkansas, United States
๐บ๐ธGastroenterology Associates of Fairfield County, Bridgeport, Connecticut, United States
๐บ๐ธPalmetto Research, Hialeah, Florida, United States